Andrew R. Garbarino sold Oramed Pharmaceuticals Inc (NASDAQ: ORMP)
Andrew R. Garbarino (R-NY), a U.S. Representative, has disclosed 3 trades in Oramed Pharmaceuticals Inc (ORMP) since 2021, 1 purchase and 2 sales, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Andrew R. Garbarino sold $1,001 - $15,000 of Oramed Pharmaceuticals Inc (NASDAQ: ORMP) on October 1, 2021. Since that trade, ORMP is down -80.17% against the S&P 500 up +81.72%, an outperformance of -161.88%.
Across these filings, Andrew R. Garbarino has been a net seller of ORMP (a buy-to-sell ratio of 0.50). The most recent disclosed ORMP transaction shown was dated January 14, 2022. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Andrew R. Garbarino's ORMP trades vs the price
ORMP is down -80.17% since Andrew R. Garbarino sold on October 1, 2021, versus +81.72% for the S&P 500.
Performance since this trade
All Andrew R. Garbarino ORMP trades
Andrew R. Garbarino & ORMP trading FAQ
Is it legal for Andrew R. Garbarino to trade Oramed Pharmaceuticals Inc (ORMP) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Oramed Pharmaceuticals Inc (ORMP), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Andrew R. Garbarino sell ORMP?
Andrew R. Garbarino disclosed a sale of $1,001 - $15,000 of Oramed Pharmaceuticals Inc (ORMP) on October 1, 2021, according to public STOCK Act filings.
How has ORMP performed since Andrew R. Garbarino's trade?
Since Andrew R. Garbarino sold ORMP on October 1, 2021, the stock is down -80.17%, versus +81.72% for the S&P 500 over the same period, an outperformance of -161.88%.
How many times has Andrew R. Garbarino traded ORMP?
Andrew R. Garbarino has disclosed 3 ORMP trades since 2021 (1 purchase and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ORMP trades?
BullishWhales tracks every disclosed congressional trade in Oramed Pharmaceuticals Inc (ORMP) on the Oramed Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Andrew R. Garbarino's ORMP tradesAll congressional filings for Oramed Pharmaceuticals IncAndrew R. Garbarino's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.